Skip to content


Breast Cancer Research

Open Access

Articles selected in January 2005

Breast Cancer Research20057:E4

Published: 15 February 2005

Articles selected

Authors’ Affiliations

Breast Center, Baylor College of Medicine and the Methodist Hospital, Houston, USA


  1. Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS, ATAC Trialists' Group: Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet. 2005, 365: 60-62. []View ArticlePubMedGoogle Scholar
  2. Al-Kuraya K, Schraml P, Torhorst J, Tapia C, Zaharieva B, Novotny H, Spichtin H, Maurer R, Mirlacher M, Köchli O, et al: Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Research. 2004, 64: 8534-8540. []View ArticlePubMedGoogle Scholar
  3. Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, et al: Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Research. 2004, 64: 8891-8900. []View ArticlePubMedGoogle Scholar
  4. Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massague J: Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest. 2005, 115: 44-55. []View ArticlePubMedPubMed CentralGoogle Scholar
  5. Clarke RB, Spence K, Anderson E, Howell A, Okano H, Potten CS: A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev Biol. 2005, 277: 443-456. []View ArticlePubMedGoogle Scholar
  6. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE: Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst. 2004, 96: 1856-1865. []View ArticlePubMedGoogle Scholar


© The Author(s) 2005